Global Pathology Market Growth Drivers, Trends, and Forecast by 2031

The Pathology Market is expected to register a CAGR of 13.0% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

Global Pathology Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, Consumables, Services, Software); Type (Human Pathology, Animal Pathology); Application (Disease Diagnosis, Drug Discovery, Training and Education, Others); End User (Hospitals, Pharmaceutical Companies, Research Institutes); and Geography (North America, Europe, Asia Pacific, and South and Central America)

Purpose of the Report

The report Pathology Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

• Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
• Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
• Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Pathology Market Segmentation

Product

• Instruments
• Consumables
• Services
• Software

Type

• Human Pathology
• Animal Pathology

Application

• Disease Diagnosis
• Drug Discovery
• Training and Education
• Others

End User

• Hospitals
• Pharmaceutical Companies
• Research Institutes

Global Pathology Market: Strategic Insights

Pathology Market Growth Drivers

• Rise in Health Concerns: Rising health concerns have led to increased demand for public and private medical laboratories and research laboratories in the UAE. The primary focus of medical laboratories is clinical research, where they offer several testing services. For instance, MaxMed laboratories, Al Rayan Medical Laboratory, and Al Tiraq Laboratory are clinical laboratories where blood sample collection and analysis procedures are performed daily, as per the laboratory's standard guidelines. Moreover, these laboratories have special facilities for blood sample preparation and storage of blood specimens. Further, in October 2022, the Dubai Health Authority (DHA) announced the launching the UAE's first-of-its drive-through blood test services.
• Certifications: The UNILABS will provide this new service, recognized by the ISO-certified Emirates International Accreditation Center (EIAC) in collaboration with the United Medical Center (UMC) in Dubai. By launching such a service, the customers can undergo drive-through blood tests as recommended by the treating physicians. In addition, the Parent's Guide to Cord Blood Foundation 2022 report states that most of the biobanks in the UAE are either cord blood banks or adipose stromal cell banks. Cord blood banking is one such example. A 2020 law was passed by the UAE Ministry of Health that became effective in January 2022, aiming for banks to collect cord blood units in the UAE to set up a laboratory and storage facility inside the UAE.
• Advanced Solutions: The process of rejuvenating, replacing, regenerating, and restoring cells and establishing healthy function is called regenerative medicine (RM). Also, the healthcare sector in the UAE favors the growth of the RM industry. Such high growth encompasses advanced biotherapies such as cell therapy, immunomodulation therapy, gene therapies, and tissue engineering, where blood sample/specimen collection and storage plays a critical role. For instance, in 2020, the Government of Dubai passed a law that focuses on the regulations on autologous adipose cellular therapies coupled with blood collection/specimen for research activities.

Pathology Market Future Trends

• High Prevalence of Blood Transfusion: There is a high prevalence of blood transfusion in major orthopedic and cardiovascular procedures. People highly prefer contactless blood collection to avoid the risk of infection and contamination during these procedures. This is likely to increase the demand for advanced healthcare infrastructure with improved facilities in hospitals
• Advanced Facilities: Countries in MENAT are introducing advanced healthcare facilities and services to overcome critical health issues. Several pathology laboratories and diagnostic centers have initiated blood collection at home services. Further, many companies launched home blood collection devices as such services became popular during the COVID-19 pandemic due to movement restrictions and social distancing norms. They are exercising strong leadership to address serious shortcomings in providing safe and good quality healthcare services..
• Rising number of Healthcare Staffs: State-of-art with new hospital complexes and hi-tech equipment with plenty of well-qualified staff Saudi Arabia has a good healthcare system with much of the high-tech equipment imported and a network of 2,000 healthcare centers within the province. These aspects are likely to offer lucrative opportunities to the market players, which is expected to fuel the growth of the MENAT vacuum blood collection tube market in the coming years.

Pathology Market Opportunities

• Hereditary blood disorders (HBD): Hereditary blood disorders (HBD) are a heterogeneous group of disorders characterized by a bleeding tendency of variable severity. Blood tests are conducted in order to detect blood disorders. As per the Annals of Saudi Medicine report, carrier screening (CS) is widely implemented in Saudi Arabia to identify reproductive carriers and reduce the consequences of single gene disorders. For example, more than half of the Saudi population is in a consanguineous marriage, which reflects an increasing number of autosomal recessive (AR) conditions
• Innovation and Research Investment: Saudi Arabia has the highest AR birth rate globally, with mutations accounting for 40% of the total mutation pools responsible for suffering from sickle cell anemia, cystic fibrosis, and Tay-Sachs disease. Further, sickle cell disease (SCD) is a common multisystem hereditary blood disorder in Saudi Arabia. For studies, studies reveal that SCD accounts for 2%-27% were carriers of sickle cell trait and 1.4% suffering from SCD as per the estimates published by the International Journal of Medicine in Developing Countries.
• Genetic Disorders: The Centre for Arab Genomic Studies, Dubai, UAE report states that genetic disorders in the Kingdom of Saudi Arabia (KSA) follow the unexpected trend of predominantly recessive disease transmission among the Arab population. For example, the two largest exome studies in KSA revealed that 71-83% of recessive mutation cases are positive for genetic disorders. The high prevalence of high rate of consanguineous marriages as a common practice among the Saudi population. Also, approx. 67.3% of KSA-CTGA disease records involve disorders transmitted through recessive inheritance. autosomal and X-linked disorders, as well as disorders classified with other relatively rarely reported forms of inheritance (sporadic, mosaic, Y-linked, mitochondrial, multifactorial, digenic inheritance, and different descriptions of transmission modes of the same disease reported between affected families are such examples. Thus, the rising prevalence of blood disorders and other genetic disorders among patients accelerates demand for vacuum blood collection tube ultimately driving the overall market growth during the forecast period.

Global Pathology Market Regional Insights

The regional trends and factors influencing the Global Pathology Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Global Pathology Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Global Pathology Market Report Scope

Global Pathology Market Players Density: Understanding Its Impact on Business Dynamics

The Global Pathology Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Global Pathology Market are:

1. Leica Biosystems
2. GE Healthcare
3. Hamamatsu Photonics K.K
4. microDimensions GmbH
5. Mikroscan Technologies, Inc.

Disclaimer: The companies listed above are not ranked in any particular order.

Key Selling Points

• Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Pathology Market, providing a holistic landscape.
• Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
• Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
• Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Pathology Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.